Pradaxa (dabigatran etexilate mesylate), a new oral anticoagulant, achieved Food & Drug Administration (“FDA”) approval on October 19, 2010. One notable advantage of using Pradaxa to replace Warfarin to prevent clot formation is the elimination of INR testing in patients taking Pradaxa. INR is the acronym for International Normalized Ratio, which is used to monitor the effectiveness of anticoagulant such as warfarin.
Free Consultation Today
800-780-8607
Review Us
Our Fee Promise:
No Recovery? No Fee.
- Actos
- Announcement
- Articles
- Blog
- Aviation Disasters
- Bike Accidents
- Boating Accidents
- Car Accidents
- Cases
- Commercial Litigation
- Corporate Fraud
- Defective Design
- Do You Know?
- Environmental Disasters
- Golf Cart Accidents
- Intellectual Property
- Law Technology
- Mass Torts
- Medical Malpractice
- Miscellaneous
- Motorcycle Accidents
- Personal Injury
- Politics and Topical News
- Premises Liability
- Product Defect
- Professional Liability
- Railroad Disasters
- Sexual Assault
- Trucking Accidents
- Wrongful Death
- Common Questions
- Defective Drugs
- Defective Medical Devices
- General
- Hot Topics
- Mass Tort News
- Motorcycle Accidents
- Pradaxa
- Product Liability
- Rejuvenate/ABG II
- Slip and Fall
- Transvaginal Mesh
- Truck Accidents
View Our Brochure